What African Patients, Clinicians, and Regulators Can Gain from Pharmacometrics: Forecasts for the Future in a New Era in Health
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Steven E Kern. Beteiligte Einrichtung: Global Health Labs, Bellevue, Washington, USA. Hauptthemen laut MEDLINE: Drug Development, Drug and Narcotic Control. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
With the growth of African national regulatory agencies into a Pan‐African entity called the African Medicines Agency (AMA), an opportunity exists for using the best regulatory science methods available. AI‐supported model‐informed drug development could be the backbone to support regulatory decision‐making efforts. The pharmacometrics community can play a pivotal role in advancing this state‐of‐the‐art opportunity. But, to do this successfully, pharmacometricians must gain the trust of African regulators, clinicians, and patients in using model‐based methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Global Health Labs, Bellevue, Washington, USA.
ORCID-Profile: Steven E Kern
Zitieren
APA
Kern, S. E. (2025). What African Patients, Clinicians, and Regulators Can Gain from Pharmacometrics: Forecasts for the Future in a New Era in Health. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70167
Vancouver
Kern SE. What African Patients, Clinicians, and Regulators Can Gain from Pharmacometrics: Forecasts for the Future in a New Era in Health. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70167
BibTeX
@article{Kern2025,
author = {Kern, Steven E},
title = {What African Patients, Clinicians, and Regulators Can Gain from Pharmacometrics: Forecasts for the Future in a New Era in Health},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.70167}
}
EUVIMED